Drug Type Small molecule drug |
Synonyms NSL-95301 |
Target |
Action antagonists |
Mechanism GP IIb/IIIa antagonists(Integrin alpha-IIb/beta-3 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC26H32N4O4 |
InChIKeyUPZSBIRXZBWTNA-UHFFFAOYSA-N |
CAS Registry180180-51-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Angina Pectoris | Discovery | Japan | - | |
Myocardial Infarction | Discovery | Japan | - | |
Perioperative ischaemia | Discovery | Japan | - | |
Stroke | Discovery | Japan | - |